MedTrace Logo

Ultrasound and Attenuation Imaging

NCT06552377 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 97

Last updated 2024-08-22

No results posted yet for this study

Summary

Fatty liver disease affects almost a 3rd of the United Kingdom (UK) population. Currently, this is being investigated using a type of MRI scan that reports how fatty or not a person's liver is, with a liver fat score, but many patients cannot have this type of scan due to time, cost or because they have a condition which makes Magnetic Resonance Imaging (MRI) an unsafe scan for them to have. An ultrasound scan is cheaper, faster and safer for a wider variety of patients. New developments in ultrasound technology mean that instead of a Sonographer, or ultrasound operator, deciding whether your liver is fatty or not based on what they see on the scan, the ultrasound machine gives a liver fat score. This study will look at the relationship between the Sonographers' view on how fatty the liver is, compared with the liver fat score given by the new development in ultrasound technology.

Conditions

  • Non-Alcoholic Fatty Liver Disease
  • Non Alcoholic Fatty Liver
  • Non-alcoholic Steatohepatitis
  • Steatosis of Liver

Interventions

DEVICE

Ultrasound Attenuation imaging measurement

Participant to undergo conventional ultrasound scanning with attenuation measurement as well.

Sponsors & Collaborators

  • Hywel Dda Health Board

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-02-14
Primary Completion
2024-04-11
Completion
2024-04-11
FDA Device
Yes

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06552377 on ClinicalTrials.gov